在循环pDC中通过EP2和EP4传递PGE2信号的不同作用:对瘤微环境中的免疫调节的影响
Jorge Cuenca-Escalona1, Mark W D Sweep1,2, Mark A J Gorris1
1Department of Medical BioSciences, Radboud University Medical Center, Geert Grooteplein 26-28 6500HB, Nijmegen, the Netherlands.
Journal of leukocyte biology
|March 21, 2025
概括
通过EP2和EP4受体发出信号的前列腺素E2 (PGE2) 不同地影响等离子体状树突细胞 (pDCs). 准这些受体可能会逆转瘤诱导的pDC功能障碍,提供治疗潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 树突细胞 (DCs) 编排了适应性免疫,受到诸如前列腺素E2 (PGE2) 等环境因素的影响.
- 瘤微环境通常含有高的PGE2水平,这可以通过诱导DCs中的调节特征来促进免疫逃避.
- PGE2通过E-prostanoid受体2 (EP2) 和EP4在DC中发挥其作用,但它们在人体血细胞DC (pDC) 中的特定作用尚不清楚.
研究的目的:
- 调查EP2和EP4信号在人类pDC功能中的不同作用.
- 检查瘤衍生PGE2对pDCs的影响以及调节EP2/4受体的潜力.
- 了解瘤微环境中的pDCs中准PGE2-EP2/4轴的治疗含义.
主要方法:
- 研究了EP2和EP4信号对pDC成熟标记物,细胞因子生产和T细胞扩张的影响.
- 使用体外瘤模型来评估pDC对瘤衍生PGE2.2的反应.
- 分析了EP2/4受体阻塞对pDC表型的影响.
主要成果:
- PGE2-EP4信号上调成熟标志物 (CD83,HLA-DR),增强迁移 (CCR7),损害了促炎媒介产量 (干扰素α,CXCL9),并促进了抑制性CD8T细胞扩张.
- PGE2-EP2信号阻碍了成熟标志物的上调,也诱导了抑制性CD8T细胞扩张.
- 在瘤衍生PGE2.2的存在下,EP2/4封锁调节的pDC表型.
结论:
- EP2和EP4受体在人类pDC中介导着不同的功能.
- 在pDC中准PGE2-EP2/4信号轴有可能缓解瘤诱导的免疫功能障碍.
- 通过EP2/4封锁调节pDC功能可能是对抗癌症免疫逃避的治疗策略.
相关概念视频
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Interactions Between Signaling Pathways
6.2K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
329
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
329


